Updated
What drives disease? With roots dating back to the mid-19th century, the germs vs. terrain debate often fuels discord. Sure, many have heard the discussion, which centers on whether specific microorganisms or “germs” are the primary cause of disease, and on the terrain theory, which holds that disease arises primarily from an imbalance or poor…Continue reading The Germ Is The Alibi
Updated
Somewhere in Moscow, a pigeon is doing what pigeons do—flapping, gliding, showing off that smug “I own this city” energy—except this one is wearing a tiny backpack, carrying a camera, and taking directions from a neural implant. That’s the claim, anyway. A Russian neurotech firm called Neiry has been making headlines for a project called…Continue reading Sky Spies With Feathers
Updated
On February 18, 2026, President Trump signed an executive order (EO) treating elemental phosphorus and glyphosate-based herbicides like supply-chain vulnerabilities. Why? Because, in the administration’s framing, they are. Following the EO, sheer panic ensued over an order that people apparently briefly skimmed, and over one word they hate. The order, which leans on the Defense…Continue reading The Executive Order Everyone Misread
For the past 15 years, Bill Gates has been working on a project to open the most advanced nuclear facility in the world in Kemmerer, Wyoming. According to Gates, nuclear power is critical in the fight against climate change. With that in mind, he believes the world needs to “make a big bet on nuclear”…Continue reading Is Bill Gates Set to Control the U.S. & Global Nuclear Energy Markets?
Updated
Autism is on the rise, and the economic costs are projected to be staggering, according to a paper by Mark Blaxill, Political Economist Toby Rogers, Ph.D., M.P.P., and Cindy Nevison, Ph.D. Blaxill, Rogers, and Nevison studied the “monumental rise” in Autism and projected its societal and economic cost. Blaxill has co-authored three books on Autism.…Continue reading Del Bigtree Discusses the Escalating Cost of the Autism Tsunami
Updated
A study conducted on the effectiveness of the bivalent COVID-19 vaccine has surprised many at the Cleveland Clinic. The organization studied its employees to determine how the new bivalent vaccines stack up against some of the more prevalent COVID strains in circulation. The results weren’t what they expected. The study’s authors admit their surprise that…Continue reading Cleveland Clinic: More Boosters? More Likely to Get COVID-19
Updated
A triad of alarming events is happening alongside each other, interlaced with desperation for society to pay closer attention to people in need and the dangers of antidepressants. The failed pandemic response caused job loss and incomes to freefall for middle-class Americans. Those lower-income individuals were hit the hardest. The Great Barrington Declaration, whose authors and…Continue reading REVISITING ANTIDEPRESSANT DRUG DANGERS IN A POST-COVID WORLD
Updated
At the ReSViNET Conference in Lisbon, Portugal, in February 2023, GSK Vice President of Vaccine Development Ilse Dieussaert discloses why GSK abandoned its maternal RSVPreF3 vaccine trial last February. The study was a phase 3, double-blinded, saline placebo-controlled trial with participants across 24 different high and low-middle-income countries. The pregnant women were followed up to…Continue reading How GSK’s RSV Vaccine Safety Signal Opens Up Investigation for All Maternal Vaccines
Updated
In a measure that is no doubt devised as a desperate attempt to hold tight to its grasp as the self-proclaimed arbiter of global pandemics, the World Health Organization just launched a new pandemic prevention plan. Released on April 27, 2023, the WHO’s Preparedness and Resilience for Emerging Threats (PRET) Initiative’s first module focuses on…Continue reading WHO’s New Pandemic Prevention Plan: First Focus – Respiratory Pathogens
Updated
